Summary and prospect of perioperative comprehensive treatment for gastric cancer in China
10.16139/j.1007-9610.2023.01.06
- VernacularTitle:中国胃癌围术期综合治疗概述与展望
- Author:
Wentao LIU
;
Fukun LIU
- Publication Type:Journal Article
- From:
Journal of Surgery Concepts & Practice
2023;28(1):36-41
- CountryChina
- Language:Chinese
-
Abstract:
Most of the patients with gastric cancer in China have been at the middle and advanced stages during diagnostic and treatment with poor prognosis overall. Perioperative radiotherapy, chemotherapy, immune therapy and other comprehensive treatment methods for gastric cancer patients preoperative and intraoperation may reduce tumor staging, increase the rate of surgical resection and prolong the time of patient survival. Perioperative comprehensive treatment has developed more than 30 years in China. Many results from relevant research were gotten combined with laying down the consensus and guidelines, and applied to clinic in recent years. With the emergence and development of new technologies and new strategies for comprehensive treatment, perioperative comprehensive treatment and conversion therapy will improve at much extent the rate of survival for gastric cancer patients in China.
